Clinical Trial Update: Intranasal Oxytocin Treatment for Social Deficits in Children With Autism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal oxytocin for social deficits in children with autism has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: Stanford University | Conditions: Autism | Phase 2 | Status: COMPLETED | Results posted: 2018-06-06